DMD and Duchenne muscular dystrophy: Glucocorticoid therapy, a therapeutic method aiming to compensate for the lack of dystrophin, is currently the main clinical treatment for DMD, and could slow down the atrophy rate of skeletal muscle by regulating the proportion of T lymphocyte subsets and inhibiting excessive cellular immune response [11].